DexCom, Inc. Stock price

Equities

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 20:47:01 23/02/2024 GMT 5-day change 1st Jan Change
116.2 USD -1.10% Intraday chart for DexCom, Inc. -0.65% -6.29%
Sales 2024 * 4.33B 341B Sales 2025 * 5.15B 405B Capitalization 45.3B 3,568B
Net income 2024 * 673M 53.01B Net income 2025 * 882M 69.47B EV / Sales 2024 * 10.8 x
Net Debt 2024 * 1.51B 119B Net Debt 2025 * 980M 77.23B EV / Sales 2025 * 8.99 x
P/E ratio 2024 *
70.6 x
P/E ratio 2025 *
54.8 x
Employees 9,550
Yield 2024 *
-
Yield 2025 *
-
Free-Float 94.42%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.39%
1 week-0.55%
Current month-4.07%
1 month-8.43%
3 months+3.06%
6 months+11.53%
Current year-6.19%
More quotes
1 week
115.30
Extreme 115.3
119.10
1 month
114.96
Extreme 114.96
129.39
Current year
114.96
Extreme 114.96
132.03
1 year
74.75
Extreme 74.75
139.55
3 years
66.89
Extreme 66.8925
164.86
5 years
26.86
Extreme 26.86
164.86
10 years
7.02
Extreme 7.0225
164.86
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 31/10/07
Director of Finance/CFO 44 31/08/18
Chief Tech/Sci/R&D Officer 47 30/09/22
Members of the board TitleAgeSince
Director/Board Member 65 19/11/09
Director/Board Member 63 18/11/14
Director/Board Member 69 08/07/09
More insiders
Date Price Change Volume
23/02/24 116.3 -1.02% 3 545 483
22/02/24 117.5 +0.95% 3,037,323
21/02/24 116.4 -1.26% 2,933,632
20/02/24 117.9 +0.70% 3,198,888
16/02/24 117 -0.54% 3,971,529

Delayed Quote Nasdaq, February 23, 2024 at 02:37 pm

More quotes
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 73.6% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
117.5 USD
Average target price
146.4 USD
Spread / Average Target
+24.59%
Consensus
  1. Stock
  2. Equities
  3. Stock DexCom, Inc. - Nasdaq
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer